WithdrawnNot Applicable

Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)

Stopped: This study was never conducted due to Covid. Key informant interviews were conducted instead.

United States0Started 2021-03-02

Plain-language summary

Over 27 million Americans are diagnosed with Type 2 Diabetes Mellitus (T2DM), and their health outcomes, including hospitalization, emergency department use, and hospital readmission, are largely driven by social determinants; diabetes complications are largely attributable to unmet health-related social needs. Investigators will conduct a pilot feasibility trial of the Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT) system to inform the design of a future, fully-powered randomized controlled trial. REDD-CAT will allow clinical staff to preemptively link patients with community-based social services tailored to meet their unique needs in order to reduce avoidable hospitalization and emergency department visits.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Boston Medical Center inpatient * Lives in the greater Boston area * Diagnosis of Type 2 diabetes * English- speaking * Demonstrated willingness and capacity to consent * Age 18 or older * Has reliable telephone access Exclusion Criteria: * Currently pregnant * Has plans to leave the area for \>2 weeks in the 45 days following enrollment in the study * Diagnosis of dementia, memory loss, or memory deficit

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility - Recruitment potential: percentage of eligible patients willing to enroll in the study

Timeframe: 6 months

Feasibility - Participant burden: time required for participants to complete data collection measures

Timeframe: 6 months

Feasibility - Subject retention: percentage of patients who complete the 30-day follow-up time point

Timeframe: 30 days

Feasibility - Implementation fidelity: percentage of indicated referrals that are made

Timeframe: 30 days

Trial details

NCT IDNCT03889600

SponsorBoston Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-04-13

View on ClinicalTrials.gov More Diabetes Mellitus, Type 2 trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Feasibility - Recruitment potential: percentage of eligible patients willing to enroll in the study

Timeframe: 6 months

Feasibility - Participant burden: time required for participants to complete data collection measures

Timeframe: 6 months

Feasibility - Subject retention: percentage of patients who complete the 30-day follow-up time point

Timeframe: 30 days

Feasibility - Implementation fidelity: percentage of indicated referrals that are made

Timeframe: 30 days